News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
PERRY MARK L
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/31/2023 |
4
| PERRY MARK L (Director) has filed a Form 4 on NVIDIA CORP|
Txns:
| Gifted 2,000 shares
@ $0
Gifted 1,000 shares
@ $0
Gifted 1,000 shares
@ $0 |
|
| 02/28/2023 |
4
| PERRY MARK L (Director) has filed a Form 4 on NVIDIA CORP|
Txns:
| Sold 6,800 shares
@ $235.3089, valued at
$1.6M
Sold 6,100 shares
@ $236.2549, valued at
$1.4M
Sold 5,700 shares
@ $237.3644, valued at
$1.4M
Sold 1,400 shares
@ $237.9968, valued at
$333.2k
|
|
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2022 |
4
| PERRY MARK L (Director) has filed a Form 4 on NVIDIA CORP|
Txns:
| Sold 1,800 shares
@ $262.9, valued at
$473.2k
Sold 12,100 shares
@ $263.67, valued at
$3.2M
Sold 2,716 shares
@ $264.92, valued at
$719.5k
Sold 100 shares
@ $265.49, valued at
$26.5k
|
|
| 06/21/2021 |
4
| PERRY MARK L (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Exercised 3,037 restricted stock units
@ $0
Granted 5,600 options to buy
@ $37.09, valued at
$207.7k
Granted 3,600 restricted stock units
@ $0 |
|
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2020 |
4
| PERRY MARK L (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 29,508 shares
@ $0
Disposed/sold 21,800 options to buy
@ $10, valued at
$218k
Disposed/sold 11,000 options to buy
@ $13.6, valued at
$149.6k
Disposed/sold 11,000 options to buy
@ $14, valued at
$154k
Disposed/sold 11,000 options to buy
@ $48.85, valued at
$537.4k
Disposed/sold 6,600 options to buy
@ $47.77, valued at
$315.3k
Disposed/sold 3,000 options to buy
@ $100.27, valued at
$300.8k
|
|
| 06/23/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| PERRY MARK L (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Exercised 2,300 restricted stock units
@ $0 |
|
| 06/12/2020 |
4
| PERRY MARK L (Director) has filed a Form 4 on NVIDIA CORP|
Txns:
| Granted 712 shares
@ $0 |
|
| 05/29/2020 |
4
| PERRY MARK L (Director) has filed a Form 4 on NVIDIA CORP|
Txns:
| Sold 400 shares
@ $326.5125, valued at
$130.6k
Sold 802 shares
@ $327.9323, valued at
$263k
Sold 1,300 shares
@ $329.2785, valued at
$428.1k
Sold 1,600 shares
@ $330.3163, valued at
$528.5k
Sold 2,200 shares
@ $331.3118, valued at
$728.9k
Sold 1,100 shares
@ $332.2009, valued at
$365.4k
Sold 404 shares
@ $333.4514, valued at
$134.7k
Sold 1,202 shares
@ $335.867, valued at
$403.7k
Sold 800 shares
@ $336.9725, valued at
$269.6k
Sold 600 shares
@ $338.0933, valued at
$202.9k
Sold 600 shares
@ $339.1567, valued at
$203.5k
|
|
| 05/13/2020 |
4
| PERRY MARK L (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Sold 2,633 shares
@ $74.0088, valued at
$194.9k
Sold 1,350 shares
@ $75.4322, valued at
$101.8k
Sold 600 shares
@ $76.2842, valued at
$45.8k
Sold 13,024 shares
@ $77.7133, valued at
$1M
Sold 34,698 shares
@ $78.6481, valued at
$2.7M
Sold 1,295 shares
@ $79.1673, valued at
$102.5k
Exercised 15,000 options to buy
@ $20, valued at
$300k
Exercised 8,600 options to buy
@ $20, valued at
$172k
Exercised 15,000 options to buy
@ $18.85, valued at
$282.8k
Exercised 15,000 options to buy
@ $28.45, valued at
$426.8k
|
|
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/20/2019 |
4
| PERRY MARK L (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Granted 7,500 options to buy
@ $56.3, valued at
$422.3k
Granted 4,800 restricted stock units
@ $0 |
|
| 06/17/2019 |
4
| PERRY MARK L (Director) has filed a Form 4 on MyoKardia Inc|
Txns:
| Granted 6,600 options to buy
@ $47.17, valued at
$311.3k
Granted 2,300 restricted stock units
@ $0 |
|
| 05/28/2019 |
4
| PERRY MARK L (Director) has filed a Form 4 on NVIDIA CORP|
Txns:
| Granted 1,258 shares
@ $0 |
|
| 06/22/2018 |
4
| PERRY MARK L (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $42.25, valued at
$633.8k
|
|
| 06/14/2018 |
4
| PERRY MARK L (Director) has filed a Form 4 on MyoKardia Inc|
Txns:
| Granted 11,000 options to buy
@ $48.85, valued at
$537.4k
|
|
| 05/21/2018 |
4
| PERRY MARK L (Director) has filed a Form 4 on NVIDIA CORP|
Txns:
| Granted 963 shares
@ $0 |
|
| 02/13/2018 |
4
| PERRY MARK L (Director) has filed a Form 4 on NVIDIA CORP|
Txns:
| Sold 17,307 shares
@ $227.9312, valued at
$3.9M
|
|
| 08/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2017 |
4
| PERRY MARK L (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $28.45, valued at
$426.8k
|
|
| 06/16/2017 |
4
| PERRY MARK L (Director) has filed a Form 4 on MyoKardia Inc|
Txns:
| Granted 11,000 options to buy
@ $14, valued at
$154k
|
|
| 05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/17/2016 |
4
| PERRY MARK L (Director) has filed a Form 4 on Global Blood Therapeutics, Inc. |
| 06/09/2016 |
4
| PERRY MARK L (Director) has filed a Form 4 on MyoKardia Inc |
| 05/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/22/2012 |
4
| PERRY MARK L (Director) has filed a Form 4 on NVIDIA CORP|
Txns:
| Granted 16,281 shares
@ $0 |
|
|
|
|